(The following press release was issued by the Kenyan Ministry of Agriculture Livestock and Fisheries on November 24, 2017.) A new agency to oversee the regulation of all veterinary medicinal […]
EDINBURGH, UK, September 26, 2017 – Additional prizes have been awarded in a global US $30 million competition aimed at incentivising the development of a vaccine that is efficacious, safe […]
The availability and use of antimicrobial medicines has transformed the practice of human and animal medicine. Infections that were once lethal are now treatable, and the use of antimicrobial drugs […]
A fresh outbreak of brucellosis in India serves as a stark reminder of the need for effective control measures. In July, more than 50 cows were reported to have been […]
GALVmed’s Market Development & Access (MD&A) department in South Asia has been working with the Jeevika Trust recently to deliver training in goat rearing in Bihar, India. The trust was aware of GALVmed’s […]
Prizes awarded to three organisations at the midway point of Phase 1 EDINBURGH, UK, July 6, 2017 – Three organisations have each been awarded prizes of US $100,000 following their […]
Release date: 24 May 2017 EDINBURGH, UK, May 24, 2017 – Small ruminant experts attending this month’s International Sheep Veterinary Congress in Harrogate are being encouraged […]
(Johannesburg, 11 May 2017) In a globalising world where clusters of countries increasingly face the same challenges and seek closer cooperation to deal with these issues together, great gains can be […]
LEUVEN, Belgium, May 17th, 2017 — ViroVet NV, a leading Belgian biopharmaceutical company active in the development of innovative vaccines and antiviral drugs for livestock, is proud to announce a […]
(15th February 2015) GALVmed recently held a workshop Nairobi (19-20 January 2017) to discuss ongoing research to improve the East Coast Fever (ECF) vaccine. The vaccine, commonly known as Infection […]
